BlackRock Japan’s PTC Therapeutics PTCT Stock Holding History

BlackRock Japan’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$8K	Buy	+697	New	+$7.31K	﹤0.01%	1237
2016 Q3	–	Sell	-566	Closed	-$4K	–	1398
2016 Q2	$4K	Hold	566	–	–	﹤0.01%	1360
2016 Q1	$4K	Sell	566 -335	-37%	-$5.81K	﹤0.01%	1375
2015 Q4	$29K	Sell	901 -114	-11%	-$3.35K	﹤0.01%	1110
2015 Q3	$27K	Buy	1,015 +539	+113%	+$23.1K	﹤0.01%	1062
2015 Q2	$23K	Buy	476 +155	+48%	+$9.04K	﹤0.01%	1180
2015 Q1	$20K	Buy	321 +130	+68%	+$7.93K	﹤0.01%	1191
2014 Q4	$10K	Buy	+191	New	+$8.41K	﹤0.01%	1271
2014 Q3	–	Sell	-1,080	Closed	-$28K	–	1293
2014 Q2	$28K	Buy	+1,080	New	+$23.1K	﹤0.01%	1118

Other funds holding PTCT

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

BlackRock Japan's PTCT Position: Q4 2016 in Review

BlackRock Japan opened a new position in PTC Therapeutics (PTCT) in Q4 2016: 697 shares worth $8K. The stake represents ﹤0.01% of the portfolio and ranks #1237 among its holdings. This is a return to the name: BlackRock Japan previously reported a position in PTCT as recently as Q2 2016.

BlackRock Japan first reported a position in PTCT in Q2 2014 and has held it in 9 quarters since. The position peaked at $29K in Q4 2015. 123 funds tracked by Wall St. Rank hold PTCT as of Q4 2016.

BlackRock Japan held 697 shares of PTC Therapeutics worth $8K as of Q4 2016.
PTC Therapeutics was a new BlackRock Japan position in Q4 2016.
PTC Therapeutics made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1237 holding.
BlackRock Japan first reported a position in PTC Therapeutics in Q2 2014 and has held it in 9 quarters since.
BlackRock Japan's PTC Therapeutics position peaked at $29K in Q4 2015.
123 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.